Fibromyalgia Treatment Market Predicts Rise In Demand By 2026

Fibromyalgia Treatment Market to Perceive
Substantial Growth During 2018–2026
Fibromyalgia Treatment Market, by Drug Type (Antidepressants,
Anticonvulsants, Muscle Relaxants, Analgesics and Others), and by Distribution
Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and
Geography - Global Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Coherent Market Insights added Latest Research Report titled " Fibromyalgia Treatment
Market, by Drug Type (Antidepressants, Anticonvulsants, Muscle Relaxants, Analgesics and
Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online
Pharmacies), and Geography - Global Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026 " to its Large Report database.
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue
and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly
caused due to genetic conditions, however actual cause is still unknown. The most common symptoms
of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual
with fibromyalgia can also have symptoms such as headaches, poor concentration and depression.
Fibromyalgia symptoms can be gradually accumulated with the time or it can be done by some external
factors. Fibromyalgia treatments include therapy, medications, regular aerobic exercise, stress
reduction, and others. Furthermore, for treatment of Fibromyalgia antidepressants or pain medication
are prescribed to treat depression, anxiety, pain, and fatigue.
Fibromyalgia Treatment Market Dynamics
Increasing prevalence of Fibromyalgia is expected to augment market growth. According to National
Fibromyalgia and Chronic Pain Association, 2014, an estimated 210 million people in 2015, were
affected with fibromyalgia syndrome, accounting for 2-4% of the total world population. Moreover,
growth of the market is driven by increasing clinical trials by the manufacturers and research
organizations and launch of novel diagnostics in order to reduce the burden of the disease with early
and accurate disease diagnosis. For instance, in 2013, Innovative Med Concepts, LLC initiated the
clinical trial for the drug candidate IMC-1, for the treatment of patients with fibromyalgia. Also, in
March 2018, IQuity, a data science company launched a new blood test called Isolate Fibromyalgia,
which uses RNA gene expression analysis to detect fibromyalgia, thus aiding in efficient diagnostics,
which can provide early medical intervention.
Furthermore, various organizations are supporting research and development and providing accessible,
affordable, and appropriate treatment which is expected to augment the market growth over the forecast
period. For instance, a non-profit organization named National Fibromyalgia and Chronic Pain
Association (NFMCPA) aims to build a united patient and health care community educate and execute
advocacy programs regarding access to care, research, diagnosis and treatment for people suffering
with chronic pain from fibromyalgia and overlapping conditions.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/1691
Competitive Analysis
Key players operating in the global fibromyalgia treatment market include Eli Lilly and Company,
Pfizer Inc., Merck & Co., Johnson & Johnson, GlaxoSmithKline Plc., Novartis AG, Sanofi S.A.,
AstraZeneca, and Allergan Plc.
Fibromyalgia Treatment Market: Market Taxonomy
On the basis of drug type, the global fibromyalgia treatment market is segmented into:
•Antidepressants
•Savella (Milnacipran)
•Cymbalta (Duloxetine)
•Others
•Anticonvulsants
•Lyrica (Pregabalin)
•Others
•Muscle Relaxants
•Analgesics
•Others
On the basis of distribution channel, the global fibromyalgia treatment market is segmented into:
•Hospital Pharmacies
•Retail Pharmacies
•Online Pharmacies
Fibromyalgia Treatment Market: Regional Dynamics
Regional segmentation of the global fibromyalgia treatment market by Coherent Market Insights
comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North
America is expected to hold a dominant position in the global fibromyalgia treatment market, owing to
increasing incidence of fibromyalgia and to curb the economic burden associated with the disease in
the U.S. According to the National Fibromyalgia Association, 2015, fibromyalgia affects an estimated
10 million people in the U.S. Moreover, according to the Community Pain Center, Fibromyalgia is
responsible for a decrease in productivity by 1-2%, resulting in direct and indirect expenditures of US$
15 billion in the U.S., thus impelling the organizations and manufacturers to launch efficient therapies,
which in turn is expected to bolster the fibromyalgia treatment market in the region.
The Fibromyalgia treatment market in Europe is expected to gain significant traction, owing to the
presence of support groups providing online support combined with fund raising activities to make
treatments available for the patients. For instance, the Fibromyalgia Action UK improves the lives of
people with fibromyalgia by increasing awareness of the condition throughout the country, thereby
improving awareness and access to treatments for fibromyalgia. Also, the UK Fibromyalgia, a member
of Disability Rights UK, is focused on spreading awareness regarding Fibromyalgia condition through
magazines and social media accounts, as well as encourages National Health Society (NHS) and
private organizations to invest in new research projects.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Coherent Market Insights added Latest Research Report titled " Fibromyalgia Treatment Market, by Drug Type (Antidepressants, Anticonvulsants, Muscle Relaxants, Analgesics and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 " to its Large Report database.

Download Report